Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps)

February 20, 2021 updated by: Ain Shams University

Aspects of Diabetes Technology (Insulin Pumps) Children Perspective, a Cross - Sectional Study

This study will be prospective comparative trial comparing between insulin pumps vs Multiple daily injections (MDI) in treatment of type 1 diabetes mellitus (T1DM) in terms of health- related quality of life (HRQL) and efficacy of glycemic control (HbA1c level )

Hypothesis:

Type 1 diabetes is characterized by autoimmune destruction of insulin-secreting pancreatic b cells leading to disturbed glucose regulation and overt hyperglycemia which leads to variable consequences and complication. Consequently, individuals with type 1 diabetes have a lifelong dependency on insulin replacement therapy.

Aim of the Work:

To compare the psychosocial impact of insulin pumps versus multiple daily injections in treatment of type 1 diabetes mellitus (Via questionnaire) in terms of health-related quality of life and efficacy of glycemic control (HbA1c level).

Study Overview

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Abbasia
      • Cairo, Abbasia, Egypt, 11517
        • Ain Shams University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients from Ain shams pediatric and adolescent diabetes unit(PADU)

Description

Inclusion Criteria:

  • 1.Type 1 diabetes mellitus.
  • 2.Patients who are on insulin pumps must be for at least 3 months on them

Exclusion Criteria:

  • 1. Other types of DM e.g., T2DM, MODY.
  • 2. Patients with other comorbidities; cardiac, renal, neurological, hepatic ….etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group A (insulin pump)
30 patients who are on insulin pump.
Confidence in diabetes self care questionnaire the socioeconomic level of the family scale MINI-KID the Peds-QL
Group B (MDI)
30 patients who are on multiple daily injection.
Confidence in diabetes self care questionnaire the socioeconomic level of the family scale MINI-KID the Peds-QL

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Confidence in diabetes self care questionnaire (CIDS)
Time Frame: 10 min
the CIDS scale, assessment included HbA1c, emotional distress, fear of hypoglycemia, self-esteem, anxiety, depression, and self-care behavior. The CIDS scale is a reliable and valid measure of diabetes-specific self-efficacy for use in patients with type 1 diabetes. High psychometric similarity allows for cross-cultural comparisons.
10 min
socioeconomic level of the family scale
Time Frame: 5 minutes
Assessment of family socioeconomic standard
5 minutes
MINI-KID (Mini International Neuropsychiatric Interview )
Time Frame: 25 minutes
Mini International Neuropsychiatric Interview for Children and Adolescents
25 minutes
Evaluation of health-related quality of life (HRQL)
Time Frame: 5 minutes
HRQL was measured by the Peds-QL 4.0 11,22. The 23-item Peds-QL 4.0 generic core scales encompass (a) physical functioning (eight items), (b) emotional functioning (five items), (c) social functioning (five items), and (d) school functioning (five items). The physical health summary score (eight items) is the same as the physical functioning scale. To create the psychosocial health summary score (15 items), the mean is computed as the sum of the items divided by the number of items answered in the emotional, social, and school functioning scales.
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2020

Primary Completion (Actual)

January 17, 2021

Study Completion (Actual)

February 1, 2021

Study Registration Dates

First Submitted

February 12, 2021

First Submitted That Met QC Criteria

February 12, 2021

First Posted (Actual)

February 16, 2021

Study Record Updates

Last Update Posted (Actual)

February 23, 2021

Last Update Submitted That Met QC Criteria

February 20, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • Health related quality of life

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on T1DM

Clinical Trials on Health related quality of life

3
Subscribe